Lavender Sky Health Review

What Lavender Sky Health charges

• Sermorelin: $199/mo — for a 15 mg injectable vial filled by the named pharmacy, with no billing period stated anywhere on the page; the same page lists 15 mg at $215 from Southend, $275 from Strive and $280 from Hallandale, and a 30 mg vial at $249 from Red Rock and $275 from Alchemist, and adds sitewide that "Medication pricing shown excludes the consultation fee", which is $65 per consult for a new patient and $40 per consult for a follow-up
• Sermorelin: $125/mo — for 60 rapid-dissolve tablets from the named pharmacy, with no billing period stated; the same combination is $189 for 60 tablets from BPI/The Pharmacy Hub, a sermorelin ODT is $199 for 40 tablets from Empower, and a sermorelin/NAD+/B12 capsule is $275 for 60 from Hallandale; medication pricing shown excludes the consultation fee, which is priced separately
• NAD+: $165/mo — for a 1000 mg injection from the named pharmacy, with no billing period stated; the same page runs 1000 mg from $200 at Red Rock to $280 at Hallandale and 2000 mg from $195 at Strive, which the page labels "(best price)", to $375 at South Lake; medication pricing shown excludes the consultation fee, which is priced separately
• Glutathione: $105/mo — for a 10 mL vial from the named pharmacy, with no billing period stated; the same page lists 10 mL at $135 from Strive and 30 mL at $175 from Empower or South Lake, the latter marked temporarily unavailable; medication pricing shown excludes the consultation fee, which is priced separately
• GHK-Cu: $129/mo — for a 30 g facial serum from the named pharmacy, with no billing period stated; a 30 g topical face cream is $149 from Strive and $175 from Alchemist; medication pricing shown excludes the consultation fee, which is priced separately

A price with a pharmacy attached to it

The pricing page lists each peptide once per pharmacy that stocks it, with the quantity printed beside the figure. A reader can see what one named facility charges for a stated number of milligrams, millilitres, grams or tablets, and what a different named facility charges for the same thing.

That is unusual enough to be the reason to read this seller at all. Eleven of the fifty-three sellers compared here name the facility that fills an order, and this is one of them, which is what makes a facility possible to look up.

Nine pharmacies are named across the page. Several of them appear elsewhere in this market only as the invisible back end of somebody else's brand, and here their prices sit side by side on a page none of them owns.

It also means the same compound has more than one price on this seller's own page, and which one applies depends on which pharmacy is used. That is a fact about the offer rather than a defect in it.

Not one peptide figure states a billing period

Every peptide line here is scoped to a quantity and a pharmacy, and none of them says per month, per cycle or per anything else. The figures answer how much medication you are buying, not how often you will be charged.

This site does not fill that gap in. The qualifier on each row says the page names no period, because writing per month on these would attach a term the seller never printed.

The seller does name a period elsewhere on the same page, on its weight-loss tables, so this is not a site that cannot describe a term. It is a page where the peptide lines are priced by quantity and the reader has to supply the calendar.

One sitewide sentence is load-bearing and is repeated on every one of these rows: the medication pricing shown excludes the consultation fee. That fee is published on a page of its own, at one rate for a first visit and a lower one for a follow-up, with the stated intervals at which a follow-up is required.

The prices are hidden until you click

The pricing page renders about a fifth of its text with its toggles closed. Opening them multiplies the readable text more than fivefold, and most of the dollar figures on the page have no laid-out box at all until a control is operated.

A reader who scrolls that page without clicking sees the weight-loss tables and not a single peptide price. This site treats those figures as published, because a control on the page reveals them, and records the readings taken with the page opened.

The coverage page behaves the same way, with its detail behind the same kind of toggle. Both readings here were taken with every toggle opened.

It is worth knowing before visiting: the answer to what this seller charges is on the page, and it is not on the screen.

All fifty states, and an exclusion list per pharmacy per product

The coverage page opens by saying the practice serves patients in all fifty states and the District of Columbia, then adds that some pharmacies are unable to ship certain medications to some states. Eighteen of the fifty-three sellers here make an all-fifty claim.

What follows is the most detailed footprint disclosure in this comparison and the hardest to record. Each of the nine pharmacies gets its own list, and within a pharmacy the list changes from one product to the next: one facility excludes four states for an injectable sermorelin and six for a glutathione injection, and another excludes nineteen states for its NAD+ injections and fourteen for a sermorelin injection.

One list per seller cannot hold that. This row carries the practice's own fifty-state sentence, and the matrix is recorded in the row and repeated here rather than flattened into the field or discarded.

The practical consequence for a reader is that eligibility is a question about a specific product from a specific pharmacy, not about this seller. Some products are unavailable in more than a dozen states depending on who fills them.

How we verified this

• Read the pricing page as rendered text in a browser with every accordion toggle opened, and recorded the closed and opened text lengths so the difference is on the record.
• Audited every dollar-bearing element on the page for a laid-out box before recording any figure, so nothing hidden from a reader was counted as published.
• Took each figure from its own line, with the pharmacy name and the quantity that line states, rather than from a page-level scan.
• Excluded lines the page marks temporarily unavailable or out of stock from the recorded figures, and named them in the qualifier instead.
• Read the sitewide sentence about the consultation fee and then read the separate page that prices that consultation, rather than assuming what it costs.
• Read the coverage page with its toggles opened as well, and copied the per-pharmacy exclusion lists rather than summarising them.
• Read the privacy notice and the patient terms for the operating company, the address and the governing-law clause, and recorded that clause verbatim because it names no state.
• Confirmed the host answers a nonsense path with its own not-found page at two different path depths in the same pass, which is what makes these readings meaningful.
• Searched the published federal warning-letter record for the company name and found no letter to it. That record does not include untitled letters.
• Counted the pharmacy-naming and all-fifty claims against the current roster rather than reusing an earlier figure.